1. Wolin, Arthur R, Vincent, Melanie Y, Hotz, Taylor, Vibhakar, Rajeev, Ford, Heide L. . EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression. In Neuro-oncology, 25, 2287-2301. doi:10.1093/neuonc/noad128. https://pubmed.ncbi.nlm.nih.gov/37486991/
2. Liu, Ze-Kun, Li, Can, Zhang, Ren-Yu, Chen, Zhi-Nan, Bian, Huijie. 2021. EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling. In Molecular cancer, 20, 79. doi:10.1186/s12943-021-01377-9. https://pubmed.ncbi.nlm.nih.gov/34044846/
3. Zhang, Guoxin, Dong, Zhen, Gimple, Ryan C, Ford, Heide L, Rich, Jeremy N. 2021. Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe. In The Journal of experimental medicine, 218, . doi:10.1084/jem.20202669. https://pubmed.ncbi.nlm.nih.gov/34617969/
4. Zhang, Ting, Xu, Jinshu, Xu, Pin-Xian. 2021. Eya2 expression during mouse embryonic development revealed by Eya2lacZ knockin reporter and homozygous mice show mild hearing loss. In Developmental dynamics : an official publication of the American Association of Anatomists, 250, 1450-1462. doi:10.1002/dvdy.326. https://pubmed.ncbi.nlm.nih.gov/33715274/
5. Liu, Zhongyuan, Zhao, Long, Song, Yongsheng. 2019. Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling. In BioMed research international, 2019, 3808432. doi:10.1155/2019/3808432. https://pubmed.ncbi.nlm.nih.gov/31317026/
智鼠故事 
